Skip to main content
Top
Published in: International Journal for Equity in Health 1/2012

Open Access 01-12-2012 | Research

China’s regional inequity in pharmacist’s drug safety practice

Author: Liyang Tang

Published in: International Journal for Equity in Health | Issue 1/2012

Login to get access

Abstract

Background

The promotion of patient safety and drug safety through promotion of pharmacist’s drug safety practice was among the most important aims of China’s health delivery system reform, but regional inequity in pharmacist’s drug safety practice was still serious in China.

Methods

The 2011 national patient safety and medication error baseline survey was carried out for the first time in China, and through analyzing dataset from the survey, this study was set up to test both China’s regional inequity in pharmacist’s drug safety practice and major influencing factors for pharmacist’s drug safety practice among different districts of China.

Results

Pharmacist’s drug safety practice in regions with higher per capita GDP and more abundant medical resources was still better than that in regions with lower per capita GDP and less abundant medical resources. In all districts of China, pharmacist’s drug safety knowledge, drug safety attitude, self-perceived pressure and fatigue, hospital management quality, and hospital regulation were major influencing factors for pharmacist’s drug safety practice, while only in regions with higher per capita GDP and more abundant medical resources, hospital drug safety culture, supervisor’s work team management, cooperation atmosphere of work team, and drug safety culture of work team were major influencing factors for pharmacist’s drug safety practice.

Conclusion

Regional inequity in pharmacist’s drug safety practice still existed in China. In all districts of China, promoting pharmacist’s drug safety knowledge, drug safety attitude, self-perceived pressure and fatigue, hospital management quality, and hospital regulation could help promote pharmacist’s drug safety practice, while only in regions with higher per capita GDP and more abundant medical resources, promoting hospital drug safety culture, supervisor’s work team management, cooperation atmosphere of work team, and drug safety culture of work team could help promote pharmacist’s drug safety practice. And in regions with lower per capita GDP and less abundant medical resources, the link between pharmacist’s drug safety practice and hospital drug safety culture/supervisor’s work team management/cooperation atmosphere of work team/drug safety culture of work team should also be gradually established.
Appendix
Available only for authorised users
Literature
1.
go back to reference Du W, Guo JJ, Jing Y, Li X, Kelton CM: Drug safety surveillance in China and other countries: a review and comparison. Value Health. 2008, 11: 130-136.CrossRef Du W, Guo JJ, Jing Y, Li X, Kelton CM: Drug safety surveillance in China and other countries: a review and comparison. Value Health. 2008, 11: 130-136.CrossRef
6.
go back to reference Hou YL: ADR reports in China reached a new peak in 2005. China Pharm News. 2006, Section A1: 1- Hou YL: ADR reports in China reached a new peak in 2005. China Pharm News. 2006, Section A1: 1-
9.
go back to reference The pharmacy department of Peking University Third Hospital: Report on patient safety, drug safety and medication error in China. 2011, Beijing: Peking University Third Hospital The pharmacy department of Peking University Third Hospital: Report on patient safety, drug safety and medication error in China. 2011, Beijing: Peking University Third Hospital
10.
go back to reference Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M: Tackling the challenges to health equity in China. Lancet. 2008, 372: 1493-1501. 10.1016/S0140-6736(08)61364-1.CrossRefPubMed Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M: Tackling the challenges to health equity in China. Lancet. 2008, 372: 1493-1501. 10.1016/S0140-6736(08)61364-1.CrossRefPubMed
11.
go back to reference Feng X, Tang S, Bloom G, Segall M, Gu Y: Cooperative medical schemes in contemporary rural China. Soc Sci & Med. 1995, 41: 1111-1118. 10.1016/0277-9536(94)00417-R.CrossRef Feng X, Tang S, Bloom G, Segall M, Gu Y: Cooperative medical schemes in contemporary rural China. Soc Sci & Med. 1995, 41: 1111-1118. 10.1016/0277-9536(94)00417-R.CrossRef
12.
go back to reference Liu Y, Hu S, Fu W, Hsiao WC: Is community financing necessary and feasible for rural China?. Health Policy. 1996, 38: 155-171. 10.1016/0168-8510(96)00856-1.CrossRefPubMed Liu Y, Hu S, Fu W, Hsiao WC: Is community financing necessary and feasible for rural China?. Health Policy. 1996, 38: 155-171. 10.1016/0168-8510(96)00856-1.CrossRefPubMed
13.
go back to reference Liu Y, Hsiao WC, Eggleston K: Equity in health and health care: the Chinese experience. Soc Sci & Med. 1999, 49: 1349-1356. 10.1016/S0277-9536(99)00207-5.CrossRef Liu Y, Hsiao WC, Eggleston K: Equity in health and health care: the Chinese experience. Soc Sci & Med. 1999, 49: 1349-1356. 10.1016/S0277-9536(99)00207-5.CrossRef
14.
go back to reference Liu Y, Rao K, Hsiao WC: Medical expenditure and rural impoverishment in China. J Health Popul Nutr. 2003, 21: 216-222.PubMed Liu Y, Rao K, Hsiao WC: Medical expenditure and rural impoverishment in China. J Health Popul Nutr. 2003, 21: 216-222.PubMed
15.
go back to reference World Bank: China’s health sector-why reform is needed. 2005, Washington, DC: World Bank World Bank: China’s health sector-why reform is needed. 2005, Washington, DC: World Bank
16.
go back to reference Vincent C, Taylor-Adams S, Stanhope N: Framework for analyzing risk and safety in cultural medicine. BMJ. 1998, 316: 1154-1157. 10.1136/bmj.316.7138.1154.PubMedCentralCrossRefPubMed Vincent C, Taylor-Adams S, Stanhope N: Framework for analyzing risk and safety in cultural medicine. BMJ. 1998, 316: 1154-1157. 10.1136/bmj.316.7138.1154.PubMedCentralCrossRefPubMed
17.
go back to reference Vincent C, Stanhope N, Crowley-Murphy M: Reasons for not reporting adverse incidents: an empirical study. J Eval Clin Pract. 1999, 5 (1): 13-21. 10.1046/j.1365-2753.1999.00147.x.CrossRefPubMed Vincent C, Stanhope N, Crowley-Murphy M: Reasons for not reporting adverse incidents: an empirical study. J Eval Clin Pract. 1999, 5 (1): 13-21. 10.1046/j.1365-2753.1999.00147.x.CrossRefPubMed
18.
go back to reference Vincent C, Neale G, Woloshynowych M: Adverse events in British hospitals: preliminary retrospective review. BMJ. 2001, 322: 517-519. 10.1136/bmj.322.7285.517.PubMedCentralCrossRefPubMed Vincent C, Neale G, Woloshynowych M: Adverse events in British hospitals: preliminary retrospective review. BMJ. 2001, 322: 517-519. 10.1136/bmj.322.7285.517.PubMedCentralCrossRefPubMed
19.
go back to reference National Patient Safety Agency: Seven steps to patient safety. 2003, London: NPSA National Patient Safety Agency: Seven steps to patient safety. 2003, London: NPSA
20.
go back to reference World Health Organization: World alliance for patient safety. 2004, Geneva: WHO World Health Organization: World alliance for patient safety. 2004, Geneva: WHO
21.
go back to reference Liu Y, Rao K, Wu J, Gakidou E: China’s health system performance. Lancet. 2008, 372: 1914-1923. 10.1016/S0140-6736(08)61362-8.CrossRefPubMed Liu Y, Rao K, Wu J, Gakidou E: China’s health system performance. Lancet. 2008, 372: 1914-1923. 10.1016/S0140-6736(08)61362-8.CrossRefPubMed
22.
go back to reference Liu Y: Reforming China’s health care: for the people, by the people?. Lancet. 2009, 373: 281-283. 10.1016/S0140-6736(09)60080-5.CrossRefPubMed Liu Y: Reforming China’s health care: for the people, by the people?. Lancet. 2009, 373: 281-283. 10.1016/S0140-6736(09)60080-5.CrossRefPubMed
23.
go back to reference Qiu Y, Liu P, Xu M: Effective regulation measures for hospital drug safety. China Pharmacist. 2002, 5 (9): 538-539. Qiu Y, Liu P, Xu M: Effective regulation measures for hospital drug safety. China Pharmacist. 2002, 5 (9): 538-539.
24.
go back to reference Jia C, Dong S, Yang Y: Strengthening drug management and ensuring the safety and effectiveness of medication. China Pharmacist. 2005, 8 (2): 151-152. Jia C, Dong S, Yang Y: Strengthening drug management and ensuring the safety and effectiveness of medication. China Pharmacist. 2005, 8 (2): 151-152.
25.
go back to reference Mei D, Tang Y, Liu M: Pharmacist and medication safety. Adverse Drug Reactions J. 2005, 7 (1): 7-10. Mei D, Tang Y, Liu M: Pharmacist and medication safety. Adverse Drug Reactions J. 2005, 7 (1): 7-10.
26.
go back to reference Shao M: Guaranteeing public drug safety, and promoting the availability of drugs-drug policy issues in China. Chinese Pharmaceutical Affairs. 2005, 19 (8): 451-456. Shao M: Guaranteeing public drug safety, and promoting the availability of drugs-drug policy issues in China. Chinese Pharmaceutical Affairs. 2005, 19 (8): 451-456.
27.
go back to reference Song J: Current situation of pharmaceutical management in basic level medical institutions and improving measures. Chinese Pharmaceutical Affairs. 2006, 20 (2): 75-76. Song J: Current situation of pharmaceutical management in basic level medical institutions and improving measures. Chinese Pharmaceutical Affairs. 2006, 20 (2): 75-76.
28.
go back to reference Chen S, Kuai L: The concept and practice of national drug policy. J Pharmaceutical Prac. 2007, 25 (5): 348-351. Chen S, Kuai L: The concept and practice of national drug policy. J Pharmaceutical Prac. 2007, 25 (5): 348-351.
29.
go back to reference Dong X: Strengthen the ADR monitoring and improve the level of safety used drug. Chinese Pharmaceutical Affairs. 2008, 22 (9): 779-780. Dong X: Strengthen the ADR monitoring and improve the level of safety used drug. Chinese Pharmaceutical Affairs. 2008, 22 (9): 779-780.
30.
go back to reference Jiang Y, Wang Z: Risks of and recommendations for drug safety in primary health care institutions. Chinese J Hospital Pharmacy. 2008, 28 (19): 1709-1730. Jiang Y, Wang Z: Risks of and recommendations for drug safety in primary health care institutions. Chinese J Hospital Pharmacy. 2008, 28 (19): 1709-1730.
31.
go back to reference Wang Y: Analysis of how to do best in current food and drug administration. Chinese Pharmaceutical Affairs. 2008, 22 (2): 93-95. Wang Y: Analysis of how to do best in current food and drug administration. Chinese Pharmaceutical Affairs. 2008, 22 (2): 93-95.
32.
go back to reference Wang X, Zhang B, Zhang M, Wang Z: Preventing drug safety problems and guaranteeing public drug safety. J Changchun University of Traditional Chinese Medicine. 2008, 24 (6): 673-674. Wang X, Zhang B, Zhang M, Wang Z: Preventing drug safety problems and guaranteeing public drug safety. J Changchun University of Traditional Chinese Medicine. 2008, 24 (6): 673-674.
33.
go back to reference Wu X, Chen Y: Functions and roles of pharmacists in drug safety practice. Contemporary Med. 2008, 5: 37-38. Wu X, Chen Y: Functions and roles of pharmacists in drug safety practice. Contemporary Med. 2008, 5: 37-38.
34.
go back to reference Jiang B, Chen J, Yan Y, Shi L: A preliminary study on drug safety in China. Chinese J Pharmacentical Technolgy Economics & Management. 2009, 3 (10): 81-84. Jiang B, Chen J, Yan Y, Shi L: A preliminary study on drug safety in China. Chinese J Pharmacentical Technolgy Economics & Management. 2009, 3 (10): 81-84.
35.
go back to reference Ren X, Tang J: Exploring the implementation of hospital pharmacist responsibility system. China Pharmacist. 2009, 12 (10): 1484-1485. Ren X, Tang J: Exploring the implementation of hospital pharmacist responsibility system. China Pharmacist. 2009, 12 (10): 1484-1485.
36.
go back to reference Ruan J: Pharmacist’s intervention for drug management in clinical departments. Herald of Medicine. 2009, 28 (8): 1100-1101. Ruan J: Pharmacist’s intervention for drug management in clinical departments. Herald of Medicine. 2009, 28 (8): 1100-1101.
37.
go back to reference Wang F: Drug safety issues and management strategies. Strait Pharmaceutical J. 2010, 22 (8): 286-262. Wang F: Drug safety issues and management strategies. Strait Pharmaceutical J. 2010, 22 (8): 286-262.
38.
go back to reference Xie X, Wang M: Hospital drug management status and recommendations for drug management improvement. China Modern Med. 2010, 17 (31): 138-141. Xie X, Wang M: Hospital drug management status and recommendations for drug management improvement. China Modern Med. 2010, 17 (31): 138-141.
39.
go back to reference Chu C, Wang Y, Fu P, Bai Z: Clinical departments should pay attention to drug management and hidden drug safety problems, and continuously improve related measures. Chinese J Ethnomedicine and Ethnopharmacy. 2011, 20 (1): 195- Chu C, Wang Y, Fu P, Bai Z: Clinical departments should pay attention to drug management and hidden drug safety problems, and continuously improve related measures. Chinese J Ethnomedicine and Ethnopharmacy. 2011, 20 (1): 195-
40.
go back to reference Agency for Healthcare Research and Quality: Hospital survey on patient safety culture. 2011, Rockville: Agency for Healthcare Research and Quality Agency for Healthcare Research and Quality: Hospital survey on patient safety culture. 2011, Rockville: Agency for Healthcare Research and Quality
Metadata
Title
China’s regional inequity in pharmacist’s drug safety practice
Author
Liyang Tang
Publication date
01-12-2012
Publisher
BioMed Central
Published in
International Journal for Equity in Health / Issue 1/2012
Electronic ISSN: 1475-9276
DOI
https://doi.org/10.1186/1475-9276-11-38

Other articles of this Issue 1/2012

International Journal for Equity in Health 1/2012 Go to the issue